Rocket Pharmaceuticals, Inc. (RCKT)
2.18
-0.18
(-7.63%)
USD |
NASDAQ |
Oct 16, 16:00
2.21
+0.03
(+1.38%)
After-Hours: 20:00
Rocket Pharmaceuticals Free Cash Flow : -170.40M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -170.40M |
| March 31, 2026 | -179.81M |
| December 31, 2025 | -190.49M |
| September 30, 2025 | -202.83M |
| June 30, 2025 | -206.17M |
| March 31, 2025 | -212.93M |
| December 31, 2024 | -215.68M |
| September 30, 2024 | -202.43M |
| June 30, 2024 | -210.55M |
| March 31, 2024 | -209.83M |
| December 31, 2023 | -211.53M |
| September 30, 2023 | -236.83M |
| June 30, 2023 | -219.40M |
| March 31, 2023 | -206.33M |
| December 31, 2022 | -186.93M |
| September 30, 2022 | -159.15M |
| June 30, 2022 | -146.46M |
| March 31, 2022 | -145.75M |
| December 31, 2021 | -129.08M |
| September 30, 2021 | -129.56M |
| June 30, 2021 | -119.60M |
| March 31, 2021 | -105.58M |
| Date | Value |
|---|---|
| December 31, 2020 | -109.26M |
| September 30, 2020 | -106.22M |
| June 30, 2020 | -102.04M |
| March 31, 2020 | -99.42M |
| December 31, 2019 | -87.93M |
| September 30, 2019 | -80.64M |
| June 30, 2019 | -75.17M |
| March 31, 2019 | -60.37M |
| December 31, 2018 | -55.24M |
| September 30, 2018 | -39.56M |
| June 30, 2018 | -31.57M |
| March 31, 2018 | -24.48M |
| December 31, 2017 | -16.72M |
| September 30, 2017 | -21.98M |
| June 30, 2017 | -27.13M |
| March 31, 2017 | -32.60M |
| December 31, 2016 | -37.75M |
| September 30, 2016 | -33.60M |
| June 30, 2016 | -28.98M |
| March 31, 2016 | -24.84M |
| December 31, 2015 | -17.83M |
| September 30, 2015 | -13.69M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | 58.34M |
| Intellia Therapeutics, Inc. | -348.69M |
| Beam Therapeutics, Inc. | -372.77M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.61M |
| Cash from Investing (Quarterly) | 214.36M |
| Cash from Financing (Quarterly) | 0.15M |
| Free Cash Flow Per Share (Quarterly) | -0.346 |
| Free Cash Flow to Equity (Quarterly) | -39.66M |
| Free Cash Flow to Firm (Quarterly) | -39.18M |
| Free Cash Flow Yield | -69.48% |